Enlarged cross-sectional area in peripheral nerves in Swedish patients with hereditary V30M transthyretin amyloidosis

References

• Arno S, Cowger J. The genetics of cardiac amyloidosis. Heart Fail Rev. 2022;27(5):1–11. doi: 10.1007/s10741-021-10164-z.
   PubMed Web of Science ®Google Scholar
• Holmgren G, Costa PM, Andersson C, et al. Geographical distribution of TTR met30 carriers in Northern Sweden: discrepancy between carrier frequency and prevalence rate. J Med Genet. 1994;31(5):351–354. doi: 10.1136/jmg.31.5.351.
   PubMed Web of Science ®Google Scholar
• Olsson M, Jonasson J, Cederquist K, et al. Frequency of the transthyretin V30m mutation in the Northern Swedish population. Amyloid. 2014;21(1):18–20. doi: 10.3109/13506129.2013.860027.
   PubMed Web of Science ®Google Scholar
• Sousa A, Andersson R, Drugge U, et al. Familial amyloidotic polyneuropathy in Sweden: geographical distribution, age of onset, and prevalence. Hum Hered. 1993;43(5):288–294. doi: 10.1159/000154146.
   PubMed Web of Science ®Google Scholar
• Gorram F, Olsson M, Alarcon F, et al. New data on the genetic profile and penetrance of hereditary V30m transthyretin amyloidosis in Sweden. Amyloid. 2021;28(2):84–90. doi: 10.1080/13506129.2020.1841623.
   PubMed Web of Science ®Google Scholar
• Sousa A, Coelho T, Barros J, et al. Genetic epidemiology of familial amyloidotic polyneuropathy (FAP)-type I in povoa do varzim and vila do conde (North of Portugal). Am J Med Genet. 1995;60(6):512–521. doi: 10.1002/ajmg.1320600606.
   PubMed Web of Science ®Google Scholar
• Hammarstrom P, Wiseman LR, Powers ET, et al. Prevention of transthyretin amyloid disease by changing protein misfolding energetics. Science. 2003;299(5607):713–716. doi: 10.1126/science.1079589.
   PubMed Web of Science ®Google Scholar
• Adams D. Hereditary and acquired amyloid neuropathies. J Neurol. 2001;248(8):647–657. doi: 10.1007/s004150170109.
   PubMed Web of Science ®Google Scholar
• Ihse E, Ybo A, Suhr OB, et al. Amyloid fibril composition is related to the phenotype of hereditary transthyretin V30M amyloidosis. J Pathol. 2008;216(2):253–261. doi: 10.1002/path.2411.
   PubMed Web of Science ®Google Scholar
• Karam C, Dimitrova D, Christ M, et al. Carpal tunnel syndrome and associated symptoms as first manifestation of ATTRv amyloidosis. Neurol Clin Pract. 2019;9(4):309–313. doi: 10.1212/CPJ.0000000000000640.
   PubMedGoogle Scholar
• Padua L, Coraci D, Erra C, et al. Carpal tunnel syndrome: clinical features, diagnosis, and management. Lancet Neurol. 2016;15(12):1273–1284. doi: 10.1016/S1474-4422(16)30231-9.
   PubMed Web of Science ®Google Scholar
• Holmgren G, Ericzon BG, Groth CG, et al. Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis. Lancet. 1993;341(8853):1113–1116. doi: 10.1016/0140-6736(93)93127-m.
   PubMed Web of Science ®Google Scholar
• Schwartzlow C, Kazamel M. Hereditary transthyretin amyloidosis: clinical presentation and management updates. J Clin Neuromuscul Dis. 2020;21(3):144–156. doi: 10.1097/CND.0000000000000270.
   PubMedGoogle Scholar
• Adams D, Gonzalez-Duarte A, O’Riordan WD, et al. Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis. N Engl J Med. 2018;379(1):11–21. doi: 10.1056/NEJMoa1716153.
   PubMed Web of Science ®Google Scholar
• Coelho T, Yarlas A, Waddington-Cruz M, et al. Inotersen preserves or improves quality of life in hereditary transthyretin amyloidosis. J Neurol. 2020;267(4):1070–1079. doi: 10.1007/s00415-019-09671-9.
   PubMed Web of Science ®Google Scholar
• Gertz MA, Mauermann ML, Grogan M, et al. Advances in the treatment of hereditary transthyretin amyloidosis: a review. Brain Behav. 2019;9(9):e01371. doi: 10.1002/brb3.1371.
   PubMed Web of Science ®Google Scholar
• Luigetti M, Romano A, Di Paolantonio A, et al. Diagnosis and treatment of hereditary transthyretin amyloidosis (ATTRv) polyneuropathy: current perspectives on improving patient care. Ther Clin Risk Manag. 2020;16:109–123. doi: 10.2147/TCRM.S219979.
   PubMed Web of Science ®Google Scholar
• Maruyama K, Ikeda S, Yanagisawa N, et al. Diagnostic value of abdominal fat tissue aspirate in familial amyloid polyneuropathy. J Neurol Sci. 1987;81(1):11–18. doi: 10.1016/0022-510x(87)90180-8.
   PubMed Web of Science ®Google Scholar
• Blom S, Steen L, Zetterlund B. Familial amyloidosis with polyneuropathy – type 1. A neurophysiological study of peripheral nerve function. Acta Neurol Scand. 1981;63(2):99–110. doi: 10.1111/j.1600-0404.1981.tb00753.x.
   PubMed Web of Science ®Google Scholar
• Heldestad V, Nordh E. Quantified sensory abnormalities in early genetically verified transthyretin amyloid polyneuropathy. Muscle Nerve. 2007;35(2):189–195. doi: 10.1002/mus.20689.
   PubMed Web of Science ®Google Scholar
• Heldestad V, Linder J, Sellersjö L, et al. Reproducibility of thermal perception and pain thresholds in quantitative sensory testing with the method of limits. Clin Neurophysiol. 2010;121(11):1878–1885. doi: 10.1016/j.clinph.2010.03.055.
   PubMed Web of Science ®Google Scholar
• Telleman JA, Herraets IJT, Goedee HS, et al. Nerve ultrasound a reproducible diagnostic tool in peripheral neuropathy. Neurology. 2019;92:e443–e450. doi: 10.1212/WNL.0000000000006856.
   PubMed Web of Science ®Google Scholar
• Ehler E. Median nerve ultrasonography in carpal tunnel syndrome. Clin Neurophysiol Pract. 2017;2(2):186–187. doi: 10.1016/j.cnp.2017.09.001.
   PubMedGoogle Scholar
• Klauser AS, Buzzegoli T, Taljanovic MS, et al. Nerve entrapment syndromes at the wrist and elbow by sonography. Semin Musculoskelet Radiol. 2018;22(3):344–353. doi: 10.1055/s-0038-1641577.
   PubMed Web of Science ®Google Scholar
• Sueyoshi T, Ueda M, Jono H, et al. Transthyrein-derived amyloidosis in musculoskeletal systems. Amyloid. 2011;18(1):163–165. doi: 10.3109/13506129.2011.574354061.
   PubMedGoogle Scholar
• Said G, Planté-Bordeneuve V. Familial amyloid polyneuropathy: a clinic-pathologic study. J Neurol Sci. 2009;284(1–2):149–154. doi: 10.1016/j.jns.2009.05.001.
   PubMed Web of Science ®Google Scholar
• Granata G, Luigetti M, Coraci D, et al. Ultrasound evaluation in transthyretin-related amyloid neuropathy. Muscle Nerve. 2014;50(3):372–376. doi: 10.1002/mus.24168.
   PubMed Web of Science ®Google Scholar
• Podnar S, Sarafov S, Tournev I, et al. Peripheral nerve ultrasonography in patients with transthyretin amyloidosis. Clin Neurophysiol. 2017;128(4):505–511. doi: 10.1016/j.clinph.2017.01.013.
   PubMed Web of Science ®Google Scholar
• Salvalaggio A, Coraci D, Cacciavillani M, et al. Nerve ultrasound in hereditary transthyretin amyloidosis: red flags and possible progression biomarkers. J Neurol. 2021;268(1):189–198. doi: 10.1007/s00415-020-10127-8.
   PubMed Web of Science ®Google Scholar
• Barroso FA, Coelho T, Dispenzieri A, et al. Characteristics of patients with autonomic dysfuction in the transthyretin amyloidosis outcomes survey (THAOS). Amyloid. 2022;29(3):175–183. doi: 10.1080/13506129.2022.2043270.
   PubMed Web of Science ®Google Scholar
• Salvalaggio A, Coraci D, Obici L, et al. Progressive brachial plexus enlargement in hereditary thrasthyretin amyloidosis. J Neurol. 2022;269(4):1905–1912. doi: 10.1007/s00415-021-10754-9.
   PubMed Web of Science ®Google Scholar
• Leonardi L, Di Pietro G, Di Pasquale A, et al. High-resolution ultrasound of peripheral nerves in late-onset hereditary transthyretin amyloidosis with polyneuropathy: similarities and differences with CIDP. Neurol Sci. 2022;43(5):3387–3394. doi: 10.1007/s10072-021-05749-3.
   PubMed Web of Science ®Google Scholar
• Cortese A, Vegezzi E, Lozza A, et al. Diagnostic challenges in hereditary transthyretin amyloidosis with polyneuropathy: avoiding misdiagnosis of treatable hereditary neuropathy. J Neurol Neurosurg Psychiatry. 2017;88(5):457–458. doi: 10.1136/jnnp-2016-315262.
   PubMed Web of Science ®Google Scholar
• Leonardi L, Vanoli F, Fionda L, et al. Nerve ultrasonography findings as possible pitfall in differential diagnosis between hereditary transthyretin amyloidosis with polyneuropathy and chronic inflammatory demyelinating polyneuropathy. Neurol Sci. 2020;41(12):3775–3778. doi: 10.1007/s10072-020-04717-7.
   PubMed Web of Science ®Google Scholar
• Goedee HS, van der Pol WL, van Asseldonk J-TH, et al. Diagnostic value of sonography in treatment-naïve chronic inflammatory neuropathies. Neurology. 2017;88(2):143–151. doi: 10.1212/WNL.0000000000003483.
   PubMed Web of Science ®Google Scholar